Trade

with

Shire PLC
(NASDAQ: SHPG)
AdChoices
184.59
+5.44
+3.03%
After Hours :
184.54
-0.05
-0.03%

Open

181.94

Previous Close

179.16

Volume (Avg)

3.34M (2.06M)

Day's Range

180.20-185.47

52Wk Range

120.96-264.98

Market Cap.

35.21B

Dividend Rate (Yield )

0.62 (0.35%)

Beta

0.71

Shares Outstanding

196.52M

P/E Ratio (EPS)

21.69 (5.56)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Biotechnology
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 4.93B

    • Net Income

    • 665.10M

    • Market Cap.

    • 35.21B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 20.34

    • PEG (Price/Earnings Growth) Ratio

    • 5.13

    • Beta

    • 0.71

    • Forward P/E

    • 52.91

    • Price/Sales

    • 6.76

    • Price/Book Value

    • 5.93

    • Price/Cash flow

    • 23.26

      • EBITDA

      • 2.06B

      • Return on Capital %

      • 11.39

      • Return on Equity %

      • 22.02

      • Return on Assets %

      • 11.39

      • Book Value/Share

      • 31.14

      • Shares Outstanding

      • 196.52M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 0.11 (9/3/2014)

      • Dividend Declaration Date

      • 8/1/2014

      Analyst Recommendation
      10/17/2014
      Outperform
        • 1 Year Price Target

        • 92.69

        • Credit Rating

        • A-

        • Analysts

        • 8

        • EPS Estimate

        • 3.12

        • Cashflow Estimate

        • 3.61

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 20.00

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • 90.40

          • 17.04

          • Net Income

            Q/Q (last year)

          • 81.60

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • 10.30

          • 63.43

          • Net Income

            5-Year Annual Average

          • 52.20

          • 10.65

          • Dividends

            5-Year Annual Average

          • 15.36

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 83.93

            • 82.75

            • Pre-Tax Margin

            • 29.95

            • 39.38

            • Net Profit Margin

            • 20.34

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • 86.50

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 24.60

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • 16.60

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.14

              • 0.76

              • Current Ratio

              • 1.18

              • 2.92

              • Quick Ratio

              • 0.54

              • 2.35

              • Interest Coverage

              • 42.70

              • 38.02

              • Leverage Ratio

              • 1.85

              • 2.21

              • Book Value/Share

              • 31.14

              • 4.76

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 30.30

                • 238.10

                • P/E Ratio 5-Year High

                • 32.08

                • 634.30

                • P/E Ratio 5-Year Low

                • 5.91

                • 124.82

                • Price/Sales Ratio

                • 9.17

                • 8.94

                • Price/Book Value

                • 8.05

                • 8.12

                • Price/Cash Flow Ratio

                • 23.26

                • 47.85

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 22.02

                    (24.80)

                  • 37.63

                    (27.20)

                  • Return on Assets %

                    (5-Year Average)

                  • 11.39

                    (11.50)

                  • 17.22

                    (13.81)

                  • Return on Capital %

                    (5-Year Average)

                  • 18.73

                    (17.60)

                  • 21.78

                    (17.31)

                  • Income/Employee

                  • 205.26k

                  • 117.08k

                  • Inventory Turnover

                  • 1.61

                  • 1.48

                  • Asset Turnover

                  • 0.56

                  • 0.55

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  1.73B
                  Operating Margin
                  35.13
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  23.26
                  Ownership

                  Institutional Ownership

                  15.66%

                  Top 10 Institutions

                  7.86%

                  Mutual Fund Ownership

                  5.05%

                  Float

                  -

                  5% / Insider Ownership

                  0.20%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Fidelity® Select Health Care Portfolio

                  •  

                    1,280,000

                  • -0.78

                  • 0.66

                  • Waddell & Reed Advisor Core Investment F

                  •  

                    633,600

                  • 0.00

                  • 0.32

                  • iShares Nasdaq Biotechnology

                  •  

                    422,120

                  • 3.08

                  • 0.15

                  • Fidelity® Puritan® Fund

                  •  

                    404,500

                  • 0.00

                  • 0.21

                  • Franklin Biotechnology Discovery

                  •  

                    322,100

                  • 44.57

                  • 0.16

                  • Fidelity Advisor® Health Care Fund

                  •  

                    282,300

                  • 2.54

                  • 0.15

                  • Fidelity® Select Pharmaceuticals Port

                  •  

                    271,500

                  • -3.31

                  • 0.14

                  • Fidelity® Blue Chip Growth Fund

                  •  

                    209,559

                  • 30.44

                  • 0.11

                  • Vanguard Morgan™ Growth Fund

                  •  

                    196,831

                  • -8.08

                  • 0.10

                  • BlackRock Health Sciences Opps Port

                  •  

                    196,400

                  • 0.00

                  • 0.10

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Fidelity Management and Research Company

                  •  

                    3,409,259

                  • +54.86%

                  • 1.71

                  • Paulson & Company Inc

                  •  

                    3,366,539

                  • +33.07%

                  • 1.69

                  • Waddell & Reed Investment Management Co

                  •  

                    2,295,669

                  • -0.77%

                  • 1.15

                  • Arrowstreet Capital Limited Partnership

                  •  

                    1,311,415

                  • -10.90%

                  • 0.66

                  • Eaton Vance Management

                  •  

                    1,072,965

                  • -13.36%

                  • 0.54

                  • Invesco Advisers, Inc

                  •  

                    918,266

                  • -5.51%

                  • 0.46

                  • Orbimed Advisors, LLC

                  •  

                    905,200

                  • +54.21%

                  • 0.45

                  • Goldman Sachs Asset Management, L.P.

                  •  

                    865,588

                  • -17.79%

                  • 0.43

                  • Pnc Bank, National Association

                  •  

                    862,611

                  • -2.75%

                  • 0.43

                  • Renaissance Technologies Corp

                  •  

                    675,575

                  • +20.27%

                  • 0.34

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Biotechnology

                  Type

                  Classic Growth

                  Style

                  Large Growth

                  Shire PLC was registered in Jersey on 28th January, 2008. It is a specialty biopharmaceutical company that focuses on developing and marketing specialty medicines that address significant unmet patient needs. The Company unified its ...morebusiness during 2013 by integrating the operations of the Specialty Pharmaceuticals (SP), Human Genetic Therapies (HGT) and Regenerative Medicine (RM) business units into a simplified One Shire organization. The Company has four commercial units that focus exclusively on the commercial execution of its In-Line products in the following specialist therapeutic areas: Rare Diseases, Neuroscience, Gastrointestinal (GI) and Internal Medicine. The clinical development, manufacturing and marketing of the Company’s products is subject to governmental regulation in the US, the EU...more and other territories.lessless

                  Key People

                  Dr. Flemming Ornskov

                  CEO

                  Ms. Susan Kilsby

                  Chairman of the Board/Director

                  James Bowling

                  CFO

                  Dr. Steven Gillis PhD

                  Director

                  Mr. David Stout

                  Director

                  • Shire PLC

                  • 5 Riverwalk

                  • Dublin, 24

                  • JEY.Map

                  • Phone: +353 14297700

                  • Fax: -

                  • shire.com

                  Incorporated

                  2008

                  Employees

                  5,338

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: